These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32275415)

  • 21. Synthesis and antimycobacterial activity of prodrugs of sulfur dioxide (SO2).
    Malwal SR; Sriram D; Yogeeswari P; Chakrapani H
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3603-6. PubMed ID: 22572576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosis.
    Nelson KM; Viswanathan K; Dawadi S; Duckworth BP; Boshoff HI; Barry CE; Aldrich CC
    J Med Chem; 2015 Jul; 58(14):5459-75. PubMed ID: 26110337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of 4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] analogues against both active and dormant Mycobacterium tuberculosis.
    Alluri KK; Reshma RS; Suraparaju R; Gottapu S; Sriram D
    Bioorg Med Chem; 2018 May; 26(8):1462-1469. PubMed ID: 29501415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Azaaurones as Potent Antimycobacterial Agents Active against MDR- and XDR-TB.
    Campaniço A; Carrasco MP; Njoroge M; Seldon R; Chibale K; Perdigão J; Portugal I; Warner DF; Moreira R; Lopes F
    ChemMedChem; 2019 Aug; 14(16):1537-1546. PubMed ID: 31294529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elaboration of a proprietary thymidylate kinase inhibitor motif towards anti-tuberculosis agents.
    Song L; Risseeuw MDP; Froeyen M; Karalic I; Goeman J; Cappoen D; Van der Eycken J; Cos P; Munier-Lehmann H; Van Calenbergh S
    Bioorg Med Chem; 2016 Nov; 24(21):5172-5182. PubMed ID: 27614917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
    Williams JT; Haiderer ER; Coulson GB; Conner KN; Ellsworth E; Chen C; Alvarez-Cabrera N; Li W; Jackson M; Dick T; Abramovitch RB
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo potent BM635 analogue with improved drug-like properties.
    Poce G; Cocozza M; Alfonso S; Consalvi S; Venditti G; Fernandez-Menendez R; Bates RH; Barros Aguirre D; Ballell L; De Logu A; Vistoli G; Biava M
    Eur J Med Chem; 2018 Feb; 145():539-550. PubMed ID: 29335214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amino acid based prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
    Courtens C; Risseeuw M; Caljon G; Maes L; Martin A; Van Calenbergh S
    Bioorg Med Chem; 2019 Mar; 27(5):729-747. PubMed ID: 30692024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of N-benzyl-5-nitrofuran-2-carboxamide as an antitubercular agent.
    Gallardo-Macias R; Kumar P; Jaskowski M; Richmann T; Shrestha R; Russo R; Singleton E; Zimmerman MD; Ho HP; Dartois V; Connell N; Alland D; Freundlich JS
    Bioorg Med Chem Lett; 2019 Feb; 29(4):601-606. PubMed ID: 30600207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gyrase ATPase domain as an antitubercular drug discovery platform: structure-based design and lead optimization of nitrothiazolyl carboxamide analogues.
    Jeankumar VU; Renuka J; Kotagiri S; Saxena S; Kakan SS; Sridevi JP; Yellanki S; Kulkarni P; Yogeeswari P; Sriram D
    ChemMedChem; 2014 Aug; 9(8):1850-9. PubMed ID: 24962352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New prodrugs against tuberculosis.
    Mori G; Chiarelli LR; Riccardi G; Pasca MR
    Drug Discov Today; 2017 Mar; 22(3):519-525. PubMed ID: 27649942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioinformatic Mining and Structure-Activity Profiling of Baeyer-Villiger Monooxygenases from Mycobacterium tuberculosis.
    Tomas N; Leonelli D; Campoy M; Marthey S; Le NH; Rengel D; Martin V; Pál A; Korduláková J; Eynard N; Guillet V; Mourey L; Daffé M; Lemassu A; André G; Marrakchi H
    mSphere; 2022 Apr; 7(2):e0048221. PubMed ID: 35296143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbiology. Pyrazinamide--old TB drug finds new target.
    Cole ST
    Science; 2011 Sep; 333(6049):1583-4. PubMed ID: 21921185
    [No Abstract]   [Full Text] [Related]  

  • 34. 2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1.
    Neres J; Hartkoorn RC; Chiarelli LR; Gadupudi R; Pasca MR; Mori G; Venturelli A; Savina S; Makarov V; Kolly GS; Molteni E; Binda C; Dhar N; Ferrari S; Brodin P; Delorme V; Landry V; de Jesus Lopes Ribeiro AL; Farina D; Saxena P; Pojer F; Carta A; Luciani R; Porta A; Zanoni G; De Rossi E; Costi MP; Riccardi G; Cole ST
    ACS Chem Biol; 2015 Mar; 10(3):705-14. PubMed ID: 25427196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones.
    Li P; Wang B; Zhang X; Batt SM; Besra GS; Zhang T; Ma C; Zhang D; Lin Z; Li G; Huang H; Lu Y
    Eur J Med Chem; 2018 Dec; 160():157-170. PubMed ID: 30336450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis.
    Renuka J; Reddy KI; Srihari K; Jeankumar VU; Shravan M; Sridevi JP; Yogeeswari P; Babu KS; Sriram D
    Bioorg Med Chem; 2014 Sep; 22(17):4924-34. PubMed ID: 25129171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural comparison of Mtb-DHFR and h-DHFR for design, synthesis and evaluation of selective non-pteridine analogues as antitubercular agents.
    Sharma K; Tanwar O; Sharma S; Ali S; Alam MM; Zaman MS; Akhter M
    Bioorg Chem; 2018 Oct; 80():319-333. PubMed ID: 29986181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents.
    Fan D; Wang B; Stelitano G; Savková K; Shi R; Huszár S; Han Q; Mikušová K; Chiarelli LR; Lu Y; Qiao C
    J Med Chem; 2021 Oct; 64(19):14526-14539. PubMed ID: 34609861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and pharmacological evaluation of nucleoside prodrugs designed to target siderophore biosynthesis in Mycobacterium tuberculosis.
    Dawadi S; Kawamura S; Rubenstein A; Remmel R; Aldrich CC
    Bioorg Med Chem; 2016 Mar; 24(6):1314-21. PubMed ID: 26875934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of 2,4-Diaminoquinazoline in
    Melief E; Bonnett SA; Zuniga ES; Parish T
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.